Related Experiment Video
Updated: Jul 18, 2025

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
Published on: April 7, 2023
Disruption of histone acetylation homeostasis triggers cognitive dysfunction in experimental diabetes
Aanchal Aggarwal1, Binduma Yadav2, Nishtha Sharma1
1National Agri-Food Biotechnology Institute, Knowledge City, Sector-81, SAS Nagar, Punjab, India.
Abstract:
Epigenetic mechanisms related to diabetes-afflicted CNS complications are largely unknown. The present study investigated the role of histone acetylation mechanisms triggering cognitive dysfunction in the Type 1 and 2 diabetic mice model. Dynamic changes in diabetic parameters like fasting blood glucose levels, glucose tolerance test, and insulin levels were observed after the induction of diabetes. Cognitive performance was significantly diminished in T1D and T2D mice examined by the Morris water maze, novel object recognition test, and Y Maze as compared to controls. Histone profiling revealed a significant reduction in H3K9/14 and H4K12 acetylation in the cortex and hippocampus of T1D and T2D mice vs Controls. While histone deacetylase (HDAC) activity was significantly elevated in brain regions of T1D and T2D mice, the histone acetyltransferase (HAT) activity remain unchanged. Significantly increased HDAC 2, HDAC 3 protein and mRNA expression observed in T1D and T2D brain regions may corroborate for increased HDAC activity. No significant change was observed in protein and mRNA expression of HDAC 1, 5, 6, and 7 in diabetic brains. Reduced H3K9/14 and H4K12 acetylation paralleled transcriptional repression of memory-related markers BDNF, SYP, and PSD-95 in the cortex and hippocampus of T1D and T2D. Pharmacological inhibition of HDAC activity by Trichostatin A enhanced the cognitive changes observed in T1D and T2D by ameliorating BDNF, SYP, Psd-95. The present study provides a better insight into molecular mechanisms related to diabetes-dependent memory changes that can help to generate new advances for therapeutics to be developed in this area.
Insights
Diabetes impairs cognitive function through epigenetic changes, specifically reduced histone acetylation in the brain. This study reveals elevated histone deacetylase (HDAC) activity contributes to memory deficits in diabetic mice.
Area of Science:
- Neuroscience
- Epigenetics
- Metabolic Disorders
Background:
- Diabetes mellitus (Type 1 and Type 2) is linked to central nervous system (CNS) complications, including cognitive dysfunction.
- The underlying epigenetic mechanisms, particularly histone acetylation, contributing to diabetes-induced cognitive decline remain poorly understood.
Purpose of the Study:
- To investigate the role of histone acetylation and deacetylation in cognitive dysfunction in Type 1 and Type 2 diabetic mouse models.
- To explore the impact of altered epigenetic modifications on memory-related gene expression and the potential of targeting histone deacetylase (HDAC) activity for therapeutic intervention.
Main Methods:
- Induction of Type 1 and Type 2 diabetes in mice, followed by assessment of diabetic parameters.
- Evaluation of cognitive performance using behavioral tests: Morris water maze, novel object recognition, and Y Maze.
- Histone acetylation/deacetylation profiling, HAT/HDAC activity assays, and protein/mRNA expression analysis of specific HDACs in brain regions (cortex, hippocampus).
- Pharmacological inhibition of HDAC activity using Trichostatin A (TSA) to assess its effect on cognitive function and gene expression.
Main Results:
- Diabetic mice (T1D and T2D) exhibited significant cognitive deficits compared to control groups.
- A notable decrease in H3K9/14 and H4K12 acetylation was observed in the cortex and hippocampus of diabetic mice.
- Elevated histone deacetylase (HDAC) activity, specifically increased expression of HDAC 2 and HDAC 3, correlated with reduced histone acetylation.
- Reduced acetylation was associated with transcriptional repression of memory-associated genes (BDNF, SYP, PSD-95).
- Pharmacological inhibition of HDACs with TSA ameliorated cognitive impairments and restored the expression of memory-related genes.
Conclusions:
- Epigenetic dysregulation, characterized by reduced histone acetylation due to increased HDAC activity, plays a crucial role in diabetes-associated cognitive dysfunction.
- Targeting HDACs presents a promising therapeutic strategy for mitigating memory deficits in diabetic individuals.
- This research provides critical insights into the molecular mechanisms underlying diabetes-related memory impairment, paving the way for novel therapeutic development.
Related Concept Videos
Psychoneuroimmunology: Diabetes and Cancer
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...

